Industri

Annora Pharma expands collaboration with AI-native trac...

Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian...

FDA approves Enhertu for two HER2-positive early breast...

Data from the DESTINY-Breast11 and DESTINY-Breast05 Phase III trials support the...

How biomimicry is transforming personal care categories...

India’s personal care industry is undergoing a fundamental shift in how it thin...

Rise of injectables and minimally invasive procedures h...

As Aerolase expands in India, what is your strategy for enabling dermatology cl...

India’s counterfeit drug crisis and the role of AI 

India is facing a perilous rise in counterfeit high-value medicines, from cance...

Dr. Reddy’s Laboratories launches its generic Semagluti...

Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch...

Even drug-resistant cancer targets can be tackled with ...

Your work leverages AI and machine learning to optimise CAR-T cell therapy. How...

AI: Revolutionising Pharma R&D 

From one-size-fits-all to precision medicine: AI’s impact on pharma  Drug develo...

Modular Waste Receptacle

Designed by QDesign, SOTARE® is a modular family of curvilinear waste and recycl...

Rob Orvis Joins Wells as Chief Technology Officer

Wells, a leader in prefabricated building solutions, announced the appointment o...

Why Child-Resistant Vape Packaging is a Non-Negotiable

As the vape industry continues to grow, the need for dependable packaging that b...

Arna Pharma and Slate Run complete JV for new US company

The companies are also launching their first collaboratively developed product, ...

Kyowa Kirin secures FDA approval for Crysvita dosing up...

Affecting adults and children, this rare, progressive, genetic disorder impacts ...

Indulekha Bringha Hair Growth Serum completes second cl...

Indulekha has announced the successful completion of its second large clinical ...

Lupin inaugurates Atharv Ability, an advanced multidisc...

Global pharma major Lupin announced the launch of Atharv Ability, its world-cla...

A uniform pricing regime ignores the heterogeneity with...

Dr Amit Kumar: How can policy frameworks better align commercial interests in t...